Innospec (IOSP) vs Ingevity (NGVT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Ingevity (NGVT) has outperformed Innospec (IOSP) over the past year, gaining 31.3% versus a gain of 24.4%. Over five years, IOSP leads with a +14.0% price change compared with -8.4% for NGVT. Ingevity is the larger company by market cap ($2.40 billion vs $2.37 billion), about 1.0 times the size.
On valuation, Ingevity trades at a lower forward P/E (11.6x vs 15.7x for Innospec). Innospec pays a dividend yielding 1.86%, while Ingevity does not currently pay one. Innospec converts more of its revenue into profit, with a net margin of 6.6% versus -14.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IOSP | NGVT |
|---|---|---|
| Share price | $96.29 | $69.92 |
| Market cap | $2.37B | $2.40B |
| 1-day change | -1.44% | -2.09% |
| YTD return | +27.63% | +20.67% |
| 1-year return | +24.45% | +31.34% |
| 5-year return | +13.99% | -8.39% |
| P/E ratio (TTM) | 19.65 | 99.88 |
| Forward P/E | 15.66 | 11.63 |
| EPS (TTM) | $4.90 | $0.70 |
| Dividend yield | 1.86% | 0.00% |
| Annual dividend | $1.79 | $0.00 |
| Revenue (latest FY) | $1.78B | $1.17B |
| Revenue growth (YoY) | -3.65% | -2.71% |
| Net income (latest FY) | $116.60M | $-167.10M |
| Gross margin | 27.69% | 39.53% |
| Operating margin | 7.28% | 35.86% |
| Net margin | 6.56% | -14.31% |
| 52-week high | $100.48 | $79.29 |
| 52-week low | $65.51 | $45.85 |
| Distance from 52-week high | -4.17% | -11.82% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +4.90% | +27.30% |
| Average volume | 187.72K | 250.57K |
| Shares outstanding | 24.63M | 34.38M |
| Employees | 2,450 | 1,400 |
| Sector | Industrials | Industrials |
| Industry | Major Chemicals | Major Chemicals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Ingevity trades at a higher earnings multiple (99.9x vs 19.6x trailing P/E).
- Innospec offers a meaningfully higher dividend yield (1.86% vs 0.00%).
- Innospec is more profitable, keeping 6.6 cents of every revenue dollar as net income versus -14.3 cents for Ingevity.
About Innospec
IOSP stock →Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.
Industrials · Major Chemicals · 2,450 employees
About Ingevity
NGVT stock →Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Industrials · Major Chemicals · 1,400 employees
IOSP vs NGVT FAQ
Which is bigger, Innospec or Ingevity?
Ingevity (NGVT) is larger, with a market capitalization of $2.40B compared with $2.37B for Innospec (IOSP).
Which stock has performed better over the past year, IOSP or NGVT?
NGVT returned +31.34% over the past 12 months, compared with +24.45% for IOSP (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, IOSP or NGVT?
IOSP has the lower trailing P/E at 19.6, versus 99.9 for NGVT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Innospec or Ingevity?
Innospec pays a dividend yielding 1.86%, while Ingevity does not currently pay a regular dividend.
Are Innospec and Ingevity in the same industry?
Yes. Both are classified in the Major Chemicals industry within the Industrials sector.